Day: May 23, 2023

Introducing Citeline’s Sitetrove Diversity Module, Combining Robust Clinical Investigator and Site Intelligence With Patient Demographics to Support the Diversification of Clinical Trials

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) — With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” Citeline’s new Sitetrove Diversity Module marries robust site and investigator intelligence with patient age, race and

Telesis Bio to Present at SynBioBeta 2023

Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop automation solutions for synthetic biology at SynBioBeta

FloQast Introduces Compliance Management Solution for Continuous Audit Readiness and Controls Optimization

Solution integrates controls capture directly into Financial Close and other processes, reducing complexity, costs, and compliance implementation and maintenance efforts LOS ANGELES, May 23, 2023 (GLOBE NEWSWIRE) — Today, FloQast, a provider of accounting workflow automation software created by accountants for accountants, announced the launch of FloQast™Compliance Management, an advanced

JETEX INTRODUCES SUSTAINABLE AVIATION FUEL BOOK & CLAIM

Jetex signs a milestone agreement with 360 Jet Fuel Ltd. to offer sustainable aviation fuel (SAF) book and claim option to its customers globally. Through the innovative 360 GREEN FUEL book and claim platform, Jetex aims to offer greater flexibility and accessibility to SAF. Dubai, United Arab Emirates, May 23,

Junshi Biosciences Announces Acceptance of the Supplemental NDA for Toripalimab in Combination with Chemotherapy for Advanced Triple-negative Breast Cancer

SHANGHAI, China, May 23, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (“NMPA”) has accepted the supplemental new drug application (“sNDA”)

Matthews Asia Announces Beonca Yip as Head of Asia Pacific

HONG KONG, May 23, 2023 (GLOBE NEWSWIRE) — Matthews announces that Beonca Yip has joined the firm as Head of Asia Pacific. Beonca will be responsible for overseeing the firm’s business in the Asia Pacific region as well as leading its distribution activities, with a particular focus on the firm’s